New York City first to offer Paxlovid at COVID-19 testing sites
Jul 01, 2022
The ‘Test-to-Treat’ program is part of federal and city efforts to catch and treat infections early and be ready for new waves of the pandemic.
United States to send out 800,000 doses of monkeypox vaccine
Jul 28, 2022
The vaccine is meant to be given in two doses, but officials say they plan to stop offering second-vaccine appointments to stretch doses.
Frequency of long-term symptoms up with positive SARS-CoV-2 test
Sep 13, 2021
The persistence of more than four weeks of at least one initially occurring symptom was found among 76.2% of those with positive test.
White House moves to make COVID-19 antiviral pills more widely available
Apr 26, 2022
Many Americans have said they cannot find a doctor to prescribe Paxlovid or a pharmacy that has it.
U.S. declares monkeypox a public health emergency
Aug 04, 2022
The declaration will increase public awareness and education around monkeypox as well as increase testing and tracking of cases.
NIH trial underway for universal flu vaccine
Jul 13, 2022
The Phase 1 trial is testing both intranasal and intramuscular administration.
Biden plans to send 400 million N95 masks to Americans for free
Jan 19, 2022
The move follows updated mask guidance issued by the CDC late last week.
Targeted COVID-19 vaccine reminders boost uptake
Aug 11, 2021
An individual email nudge can increase COVID-19 vaccination registration among healthcare workers, according to a research letter published online July 28 in JAMA Network Open.
U.S. begins targeted vaccine rollout against monkeypox
Jun 29, 2022
HHS is rapidly expanding access to hundreds of thousands of doses of the Jynneos vaccine.
Patients report memory problems after mild COVID-19
Aug 02, 2021
Patients who self-report memory problems eight months after COVID-19 often perceive a worsening of health compared with one year prior.